Moderna rancang tubuh anak syarikat baharu di Malaysia
Syarikat bioteknologi yang merintis terapeutik dan vaksin messenger RNA (mRNA), Moderna, Inc. hari ini mengumumkan rancangan untuk menubuhkan anak syarikat baharu di Malaysia, disertai tiga anak syari
Wed Feb 16 2022
COVID-19: Vaksin Moderna kekal berkesan selepas enam bulan
Data ini hampir sama dengan dapatan 94 peratus keberkesanan yang dilaporkan dalam ujian klinikalnya sebelum ini.
Thu Aug 05 2021
Moderna's COVID-19 vaccine shows promise against Delta variant in lab study
Data shows that the vaccine was far more effective in producing antibodies against the Delta variant than it was against the Beta variant.
Wed Jun 30 2021
COVID-19: Moderna sahkan vaksin berkesan tangani mutasi baharu virus
Syarikat itu bagaimanapun mengambil langkah berjaga-jaga dengan menguji kemungkinan dos penguat tambahan terhadap mutasi yang ditemui di Afrika Selatan.
Mon Jan 25 2021
Moderna CEO confident of producing 500 million COVID-19 vaccine doses in 2021
Moderna Inc will be able to produce 500 million doses of its COVID-19 vaccine in 2021.
Sat Dec 05 2020
COVID-19: Moderna yakin 20 juta dos vaksin diperoleh sebelum akhir tahun
Daripada jumlah itu, 7 juta dos sudah siap dihasilkan dan diletakkan dalam tempat simpanan sejuk beku.
Thu Dec 03 2020
COVID-19: Moderna kemuka kelulusan kecemasan vaksin daripada FDA selepas capai tahap keberkesanan 94.1%
Moderna Inc akan mengemukakan permohonan kebenaran kecemasan daripada Pentadbiran Makanan dan Ubat-Ubatan (FDA) untuk menggunakan penghasilan vaksinnya.
Mon Nov 30 2020
Moderna to charge $25-$37 for COVID-19 vaccine: CEO tells paper
Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered.
Sun Nov 22 2020
Moderna, the small biotech company taking on the pandemic
Moderna CEO Stephane Bancel became a billionaire in April when the very preliminary results of clinical trials on a COVID-19 vaccine were first announced.
Tue Nov 17 2020